AlphaQuest’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-776
Closed -$15.3K 2109
2025
Q1
$15.3K Buy
776
+54
+7% +$1.06K ﹤0.01% 1746
2024
Q4
$16.2K Sell
722
-20,395
-97% -$459K ﹤0.01% 1439
2024
Q3
$539K Buy
21,117
+19,525
+1,226% +$499K 0.05% 625
2024
Q2
$37.2K Buy
1,592
+742
+87% +$17.3K 0.01% 1172
2024
Q1
$15K Buy
+850
New +$15K ﹤0.01% 1054